The Claim

Oral administration of apigenin reduces elevated levels of SASP-related mRNA, including IL-6 and IκBζ, in the kidneys of aged rats.

Source: Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
16score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

When aged rats are given apigenin by mouth, the levels of specific inflammatory messenger molecules in their kidneys decrease.

See the scientific wording

Oral administration of apigenin significantly reduces elevated levels of SASP-related mRNA (including IL-6 and IκBζ) in the kidneys of aged rats, demonstrating in vivo biological activity of this flavonoid in a mammalian model of age-related inflammation.

Why this might work

Apigenin blocks a key signal starter in inflamed cells, which stops a chain reaction that turns on inflammatory genes. This prevents the production of harmful proteins like IL-6 and IκBζ in kidney cells of aging organisms.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts.

    When older rats were given apigenin by mouth, the inflammatory signals in their kidneys went down, proving the compound can enter the body and calm inflammation at the gene level.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.